<DOC>
	<DOCNO>NCT00773357</DOCNO>
	<brief_summary>The purpose study examine whether guanfacine carvedilol attenuate ability stress precipitate smoking lapse behavior treatment seek non-treatment seek daily smoker . Participants seek treatment smoke participate smoking cessation attempt laboratory session . Also look gender difference .</brief_summary>
	<brief_title>Modeling Stress-precipitated Smoking Behavior Medication Development</brief_title>
	<detailed_description />
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>age 1860 able read write English smoker significant current medical condition would contraindicate smoking current DSMIV abuse dependence substance , nicotine ( caffeine ) dependence positive test result intake appointment urine drug screen conduct opiate , cocaine , benzodiazepine woman pregnant nursing suicidal , homicidal evidence severe mental illness participant prescribe psychotropic drug 30 day prior study enrollment blood donation within past 6 week participant engage quit attempt past 3 month specific exclusion administration guanfacine/carvedilol already specify include : Hypotensive individual sit blood pressure 90/50 mmHG ; EKG evidence baseline screen clinically significant conduction abnormality , include Bazlett 's QTc &gt; 450 msec men QTc &gt; 470 msec woman ; know intolerance guanfacine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>smoke lapse behavior</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>guanfacine</keyword>
	<keyword>carvedilol</keyword>
	<keyword>medication effect smoke lapse behavior</keyword>
	<keyword>medication effect smoking cessation</keyword>
	<keyword>stress</keyword>
	<keyword>gender difference</keyword>
</DOC>